Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 30 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

6%

1 of 17 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (9)
P 1 (1)
P 2 (3)
P 4 (1)

Trial Status

Completed17
Unknown6
Recruiting3
Not Yet Recruiting2
Withdrawn2

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 17 completed trials

Clinical Trials (30)

Showing 20 of 20 trials
NCT07528300Not ApplicableRecruitingPrimary

Effect of Battlefield Acupuncture on Pain Control During Inpatient Treatment of Exertional Rhabdomyolysis

NCT07433127Completed

Inflammation Indıces and Mortality in Adult Crush Syndrome

NCT07361835Not ApplicableNot Yet RecruitingPrimary

Evaluation of the Effectiveness of Using Virtual Reality Glasses in Prehospital Intervention Training for Crush Syndrome

NCT07352319Not ApplicableCompleted

DOES LOWER BODY PLYOMETRICS CAUSE RHABDOMYOLYSIS IN FEMALE VOLLEYBALL PLAYERS-AN EXPERIMENTAL STUDY

NCT01976936Phase 2Completed

Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2

NCT01544231CompletedPrimary

Plasma Neutrophil Gelatinase Associated Lipocalin Levels During Emergency Management of Rhabdomyolysis

NCT07158554Not Yet RecruitingPrimary

The Rhabdomyolysis Evaluation in the Emergency Department (REED) Score

NCT05146336Recruiting

CytOSorb TreatMent Of Critically Ill PatientS Registry

NCT07094165Not ApplicableCompleted

The Effects of Dexmedetomidine and Remifentanil on Kidney Injury After Muscle Compression Injury in Rats

NCT06491394Phase 4CompletedPrimary

Lactoferrin Effect on Kidney and Heart of Rhabdomyolysis Rats

NCT06429982Phase 1RecruitingPrimary

Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols

NCT06503289Completed

Myoglobin Removal With CytoSorb in Rhabdomyolysis

NCT01467180Not ApplicableCompletedPrimary

Myoglobin Removal by High Cut-off CVVHD

NCT04118608CompletedPrimary

Rhabdomyolysis - a Study of Patients and Laboratory Values to Guide Treatment

NCT06338423Not ApplicableCompletedPrimary

Use of a Vacuum Mattress During Laparoscopic Sleeve Gastrectomy to Reduce the Concentration of Rhabdomyolysis Markers and Acute Renal Failure

NCT03986736Completed

Markers of Tissue Injury and Rhabdomyolysis in Patients With Major Trauma

NCT04913298Not ApplicableCompletedPrimary

Prospective Study for the Application of Cytosorb® in Critically Ill Patients

NCT06101680UnknownPrimary

RhabdomYolyse in Intensive caRe

NCT02111018Phase 2WithdrawnPrimary

Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With Rhabdomyolysis

NCT04610619Unknown

Multisystem Features of Malignant Hyperthermia or Rhabdomyolysis Related to RYR1 Variants

Scroll to load more

Research Network

Activity Timeline